Post-tuberculosis lung disease [0.03%]
肺结核后遗症
Yasmeen Al-Hindawi,Onno W Akkerman,Anthony Byrne et al.
Yasmeen Al-Hindawi et al.
Tuberculosis (TB) burden concentrates in low-income settings and remains the leading global cause of death from a single infectious agent, despite that it is preventable and treatable. TB-associated lung diseases (TBALD), a broad range of r...
Ohanna Kirakosyan,Haike Verbree,Marieke M van der Zalm et al.
Ohanna Kirakosyan et al.
Tuberculosis (TB) continues to be a global clinical and public health threat, particularly in low- and middle-income countries. TB care has primarily been centred around timely diagnosis and expanding access to treatment. Post-TB lung disea...
When tuberculosis turns critical: a rare constellation of severe complications [0.03%]
当结核病变得危急时：严重并发症的罕见组合
Zainab Afzal,David Quigley,John Hogan et al.
Zainab Afzal et al.
TB is a complex multifaceted disease with varying presentations and complications. Antimicrobial treatment remains the mainstay of treatment of trachea-oesophageal fistula secondary to TB; however, invasive interventions can be considered f...
Work-life balance as early career respiratory experts and ERS representatives: personal experiences, reflections and potential solutions for improvement [0.03%]
呼吸系统专业人员的职业与生活平衡：个人经历、反思和改进方案
Mathieu Marillier,Athénaïs Boucly,Matteo Siciliano et al.
Mathieu Marillier et al.
Work-life balance is a real challenge for early career respiratory professionals striving to manage clinical responsibilities, research, teaching and professional commitments. In this collective reflection by members of the European Respira...
Breathe is voluntarily reviewed. We are most grateful to the hard work and dedication of those listed below, who reviewed articles for Breathe in 2025. C...
Rannvá Winther,Søren Sperling,Andreas Fløe
Rannvá Winther
Macrolides are known to play a key role in the treatment of nontuberculous mycobacteria. However, the optimal combination and number of drugs remains uncertain. Nagawawa et al. and Zweijpfenning et al. investigated these questions in two ra...
Secondary infections following tuberculosis: epidemiology, pathogenesis and clinical implications [0.03%]
肺结核后的继发感染：流行病学、发病机制和临床意义
Mariona Cortacans,Nino Gogichadze,Pablo Soldevilla et al.
Mariona Cortacans et al.
This review brings together global data on bacterial, fungal, nontuberculous mycobacterial (NTM) and viral infections that complicate the course of individuals following the diagnosis of pulmonary or extrapulmonary tuberculosis (TB). It sho...
Erratum: "The role of interventional pulmonology in management of pulmonary nodules during lung cancer screening." C. Carvalho, S. van Heumen, F. Funke, et al. Breathe 2025; 21: 240256 [0.03%]
关于“肺癌筛查期间支气管介入肺科在肺结节管理中的作用”的勘误：Carvalho C, van Heumen S, Funke F等. Breathe 2025; 21: 240256
[This corrects the article DOI: 10.1183/20734735.0256-2024.]. Copyright ©ERS 2026.
Published Erratum
Breathe (Sheffield, England). 2026 Jan 27;22(1):245256. DOI:10.1183/20734735.5256-2024 2026
Pulmonary infections [0.03%]
肺部感染
Imran Sulaiman
Imran Sulaiman
An introduction to two issues of Breathe that focus on pulmonary infections https://bit.ly/4aFmbGI. Copyright ©ERS 2026.
Management of adverse events in TB care and active TB drug safety monitoring [0.03%]
耐药结核病诊疗中的药物不良事件的管理及活动监测
Shamsuddeen Yusuf Ma&#x;aruf,Aparna Sharma,Shannon Fox et al.
Shamsuddeen Yusuf Ma&#x;aruf et al.
Tuberculosis (TB) remains the leading cause of death from a single infectious agent, with 10.8 million cases reported in 2023. While treatment is generally effective, both drug-susceptible (DS-TB) and drug-resistant TB (DR-TB) regimens are ...